Our team at the Center for Psychiatric Neuromodulation implements strategies beyond standard therapies to help treatment-resistance patients relieve symptoms and live a productive, fulfilling life.
Our one-of-a-kind comprehensive center in southwestern PA offers state-of-the-art neuromodulation therapies for treatment-resistant psychiatric disorders,
We know there’s no one-size-fits-all approach to behavioral health treatment. We use some advanced neuromodulation therapies to address treatment-resistant psychiatric disorders.
A unique noninvasive treatment that uses electromagnetic pulses that directly
reach deeper brain structures, which successfully influences neural activity
and helps alleviate symptoms related to mental health conditions. DTMS has been FDA-approved for management of treatment-resistant MDD and treatment-resistant OCD.
Performed under general anesthesia, ECT passes small electric currents through the brain, intentionally triggering a brief seizure. ECT seems to cause changes in brain chemistry that can quickly reverse symptoms of a range of mental health
conditions. ECT is indicated for management of MDD, bipolar disorder,
schizophrenia, and catatonia.
A neurosurgical procedure that involves implanting electrodes in the brain which
deliver electrical impulses that alter the abnormal activity that causes
symptoms in neurological and psychiatric conditions. DBS is indicated for
management of treatment-refractory OCD in addition to being approved for
treatment of Parkinson’s disease (PD), essential tremor (ET), and dystonia.
Our center also provides collaborative care and expertise in assessment and management of behavioral symptoms in Parkinson’s disease (PD) patients undergoing DBS treatment.
Our team also has a strong research focus on the impact of sleep on neuromodulation outcomes in both psychiatric and neurological disorders.